Skip to content

The study of the relationship between esketamine and sepsis-related cognitive impairment

The study of the relationship between esketamine and sepsis-related cognitive impairment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300076979
Enrollment
Unknown
Registered
2023-10-26
Start date
2023-11-20
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive impairment

Interventions

Saline group:None
Esketamine group :None

Sponsors

Shanghai Sixth People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The clinical data of 50 patients with sepsis-related cognitive impairment who were Shanghai Sixth People's Hospital from March 2018 to April 2022 were analyzed retrospectively. All patients met the diagnostic criteria for sepsis in the third edition of the international consensus definition of sepsis and septic shock (abbreviated as"Sepsis 3.0") : life-threatening organ dysfunction resulting from an out-of-control response to infection (rapid increase in SOFA score =2) ; Patients with sepsis-related cognitive impairment were sedated with ketamine (n = 25) and patients with sepsis-related cognitive impairment were sedated with saline (n = 25) . In the observation group, there were 13 males and 12 females, with an age of (70 ± 5.5) years and a body mass index (BMI) of (22 ± 1.5) kg. M-2, mean years of education (7.3 ± 4.0) A, mini-mental state examination (MMSE) score at admission (27.5 ± 1.2) . In the control group, there were 10 males and 15 females, with an age of (72 ± 5.7) years and a body mass index (BMI) of (21.5 ± 1.7) kg. M-2, mean years of education (6.9 ± 3.5) A, mini-mental state examination (MMSE) score at admission (27.7 ± 1.2) points. There was no significant difference between the two groups in sex, age, BMI, years of education and preoperative MMSE (P > 0.05) .

Exclusion criteria

Exclusion criteria: ?Patients with central nervous system disease, mental disorders or psychological disorders before operation; ? Patients with adverse effects of long-term medication on mental system function;? Patients with severe abnormality of liver and kidney function;? Patients with secondary metabolic factors such as hyperthyroidism;?Patients with severe hypertension and cerebrovascular disease;? Patients with visual and hearing impairment who can not communicate normally.

Design outcomes

Primary

MeasureTime frame
MMSE;

Secondary

MeasureTime frame
PCT;Inflammatory indicators;

Countries

China

Contacts

Public ContactXiaotao Xu

Shanghai Sixth People’s Hospital

xuxiaotao08@163.com+86 158 0058 7652

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026